These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25341929)

  • 1. Anti-metastatics: an overview of drug candidates in current pipelines.
    Schaap-Nutt A; Thyssen DA; Drell DW; Entschladen F
    Curr Pharm Des; 2014; 20(42):6522-8. PubMed ID: 25341929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targets for anti-metastatic drug development.
    Stock AM; Troost G; Niggemann B; Zänker KS; Entschladen F
    Curr Pharm Des; 2013; 19(28):5127-34. PubMed ID: 23607665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metals and metastasis: Exploiting the role of metals in cancer metastasis to develop novel anti-metastatic agents.
    Fouani L; Menezes SV; Paulson M; Richardson DR; Kovacevic Z
    Pharmacol Res; 2017 Jan; 115():275-287. PubMed ID: 27940016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges.
    Gandalovičová A; Rosel D; Fernandes M; Veselý P; Heneberg P; Čermák V; Petruželka L; Kumar S; Sanz-Moreno V; Brábek J
    Trends Cancer; 2017 Jun; 3(6):391-406. PubMed ID: 28670628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microenvironment of the tumour-host interface.
    Liotta LA; Kohn EC
    Nature; 2001 May; 411(6835):375-9. PubMed ID: 11357145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumorigenic effects of cannabinoids beyond apoptosis.
    Freimuth N; Ramer R; Hinz B
    J Pharmacol Exp Ther; 2010 Feb; 332(2):336-44. PubMed ID: 19889794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The challenge of targeting metastasis.
    Fidler IJ; Kripke ML
    Cancer Metastasis Rev; 2015 Dec; 34(4):635-41. PubMed ID: 26328524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy : Moving Benchside Promises to Patient Bedsides.
    Belaid A; Ndiaye PD; Filippakis H; Roux J; Röttinger É; Graba Y; Brest P; Hofman P; Mograbi B
    Curr Cancer Drug Targets; 2015; 15(8):684-702. PubMed ID: 26452384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting focal adhesion kinase signaling in tumor growth and metastasis.
    Schwock J; Dhani N; Hedley DW
    Expert Opin Ther Targets; 2010 Jan; 14(1):77-94. PubMed ID: 20001212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Therapeutic Potential of Migrastatin-Core Analogs for the Treatment of Metastatic Cancer.
    Giralt E; Lo Re D
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological strategies and micrometastasis: what is known? What must be done?
    Perret GY
    Minerva Med; 2010 Jun; 101(3):163-78. PubMed ID: 20562804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repositioning "old" drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.
    Shah ET; Upadhyaya A; Philp LK; Tang T; Skalamera D; Gunter J; Nelson CC; Williams ED; Hollier BG
    Clin Exp Metastasis; 2016 Apr; 33(4):385-99. PubMed ID: 26932199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of Plant Natural Products in Inhibition of Cancer Invasion and Metastasis by Regulating Multiple Signaling Pathways.
    Sarwar MS; Zhang HJ; Tsang SW
    Curr Med Chem; 2018; 25(38):5057-5087. PubMed ID: 28925869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology.
    Zheng P; Wang Q; Teng J; Chen J
    Pharmacol Res; 2015 Sep; 99():11-5. PubMed ID: 25976680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Review of the Structure-Activity Relationship of Natural and Synthetic Antimetastatic Compounds.
    Liew SK; Malagobadan S; Arshad NM; Nagoor NH
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasis awakening: the challenges of targeting minimal residual cancer.
    Polzer B; Klein CA
    Nat Med; 2013 Mar; 19(3):274-5. PubMed ID: 23467237
    [No Abstract]   [Full Text] [Related]  

  • 17. Src and focal adhesion kinase as therapeutic targets in cancer.
    Brunton VG; Frame MC
    Curr Opin Pharmacol; 2008 Aug; 8(4):427-32. PubMed ID: 18625340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Companion canines: an under-utilised model to aid in translating anti-metastatics to the clinic.
    van der Weyden L; Starkey M; Abu-Helil B; Mutsaers AJ; Wood GA
    Clin Exp Metastasis; 2020 Feb; 37(1):7-12. PubMed ID: 31691156
    [No Abstract]   [Full Text] [Related]  

  • 19. Translational research in oncology: the need of additional in vitro preclinical testing methods for new drugs.
    Drell TL; Zanker KS; Entschladen F
    Curr Pharm Des; 2012; 18(23):3416-20. PubMed ID: 22663553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental and clinical effects of anticoagulants on cancer progression.
    Van Noorden CJ; van Sluis GL; Spek CA
    Thromb Res; 2010 Apr; 125 Suppl 2():S77-9. PubMed ID: 20434011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.